Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
February 18, 2026	By:	/s/ MICHAEL G. KNELL
	Michael G. Knell
	Interim Chief Financial Officer, Corporate Senior Vice President, Chief Accounting Officer (duly authorized officer and Principal Financial and Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities indicated below and on the dates indicated.


Signatures		Title	Date
By:	/s/ JAMES C. FOSTER	Chairman, President and Chief Executive Officer	February 18, 2026
	James C. Foster

By:	/s/ MICHAEL G. KNELL	Interim Chief Financial Officer, and	February 18, 2026
	Michael G. Knell	Corporate Senior Vice President, Chief Accounting Officer (duly authorized officer and Principal Financial and Accounting Officer)




By:	/s/ NANCY C. ANDREWS	Director	February 18, 2026
	Nancy C. Andrews

By:	/s/ STEVEN BARG	Director	February 18, 2026
	Steven Barg

By:	/s/ ABRAHAM CEESAY	Director	February 18, 2026
	Abraham Ceesay

By:	/s/ MARK ENYEDY	Director	February 18, 2026
	Mark Enyedy

By:	/s/ PAUL GRAVES	Director	February 18, 2026
	Paul Graves

By:	/s/ RESHEMA KEMPS-POLANCO	Director	February 18, 2026
	Reshema Kemps-Polanco

By:	/s/ GEORGE LLADO	Director	February 18, 2026
	George Llado

By:	/s/ MARTIN MACKAY	Director	February 18, 2026
	Martin Mackay

By:	/s/ CRAIG B. THOMPSON	Director	February 18, 2026
	Craig B. Thompson

By:	/s/ VIRGINIA M. WILSON	Director	February 18, 2026
	Virginia M. Wilson

Previous: Item 15. (a)(3) and Item 15(b) Exhibits